Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Signs Biodefense CRADA with USAMRIID

NEW YORK, Nov. 18 (GenomeWeb News) - Acacia Research subsidiary CombiMatrix said today that it has signed a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) to develop microarray technology for environmental and medical detection of biothreat agents.

Financial details of the CRADA were not disclosed.

Under the agreement, USAMRIID and CombiMatrix will share consultative services, equipment, reagents, and testing support to demonstrate the effectiveness of CombiMatrix's Electrochemical Detection System for identifying biothreat agents. USAMRIID will provide appropriate reagents to CombiMatrix during the project for live agent testing in USAMRIID's secure facilities.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.